Gyre Therapeutics Inc. GYRE
$5.81
▼ -2.15% 24H
About
Gyre Therapeutics Inc. is a biotechnology firm dedicated to the discovery and development of innovative therapies for unmet medical needs. Its primary function is to leverage cutting-edge research and development technologies to address complex diseases and conditions that currently lack effective treatments. Gyre Ther…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees579
TickerGYRE
Statistics
Market Cap$530.7M
Revenue (TTM)$116.6M
Net Income$9.9M
Net Margin8.5%
EPS$0.02
P/E364.50
P/S4.92
P/B5.35
EV/EBITDA106.53
ROE-3.1%
Dividend Yield—
Price$5.81
Data: Twelve Data · Revenue = mcap / P/S